Oligonucleotide detecting CLTC-TFE3 fusion gene in sample, method and kit

A CLTC-TFE3 and fusion gene technology, which is applied in biological science and biological fields, can solve the problems of poor specificity and high cost, and achieve the effect of simple operation, high accuracy and improved experimental efficiency

Inactive Publication Date: 2019-01-18
北京艾迪康医学检验实验室有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, because SYBR GreenI is an unsaturated dye, its specificity is not as good as that of the double-probe hybridization method and the Taqman method, and its specificity must be judged by observing the melting curve; and the cost of the double-probe hybridization method is relatively expensive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oligonucleotide detecting CLTC-TFE3 fusion gene in sample, method and kit
  • Oligonucleotide detecting CLTC-TFE3 fusion gene in sample, method and kit
  • Oligonucleotide detecting CLTC-TFE3 fusion gene in sample, method and kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] For detecting the oligonucleotide of CLTC-TFE3 fusion gene in the sample, said oligonucleotide comprises: for the upstream and downstream primers and probes of CLTC-TFE3, its base sequence is respectively SEQ ID NO:1,2 and 3.

[0030]Further, the oligonucleotide also includes upstream and downstream primers and probes for the internal reference gene of β-actin, the base sequences of which are SEQ ID NO: 4, 5 and 6, respectively.

[0031] A method for detecting CLTC-TFE3 fusion gene in a sample, said method comprising the following steps:

[0032] (1) extract the RNA in the sample;

[0033] (2) Reverse transcribe the RNA extracted in (1) into cDNA;

[0034] (3) Add the cDNA described in (2) to the reaction tube, and use the upstream and downstream primers and probes for CLTC-TFE3 to detect the fluorescent signal of the CLTC-TFE3 fusion gene in the sample, and its base sequences are SEQ ID NO: 1, 2 and 3; use the upstream and downstream primers and probes for the β-act...

Embodiment 2

[0046] The operating flow of the inventive method:

[0047] (1) Extract tissue RNA from blood: Add 1ml of the erythrocyte lysate in Example 1 to a clean 1.5ml centrifuge tube, take 0.5ml of anticoagulated blood and mix well, let stand at room temperature for 10min; centrifuge at 5000rpm for 5min, discard Supernatant, collect the cells at the bottom; add 0.5ml of the erythrocyte lysate in Example 1 again, centrifuge at 5000rpm for 5min, discard the supernatant, and collect the cells at the bottom; add 1ml TRIzol to the cells, pipette repeatedly until the precipitate is completely dissolved, and stand at room temperature 5min; add 0.2ml chloroform, shake evenly; centrifuge at 14000rpm 4°C for 10min, absorb the supernatant layer and transfer to another new centrifuge tube (do not absorb the white middle layer); add an equal volume of isopropanol, mix well up and down, Let stand at room temperature for 10min; centrifuge at 14000rpm at 4°C for 10min, discard the supernatant, add 1m...

Embodiment 3

[0060] Example 3 Positive plasmid detection and sensitivity detection

[0061] When preparing positive plasmids, first directly synthesize CLTC-TFE3 cDNA, and then insert them into the previously selected plasmid plasmids (here the PMD18-T plasmid is used as an example), so that PMD18-T / CLTC-TFE3 can be prepared positive plasmid.

[0062] The prepared PMD18-T / CLTC-TFE3 positive plasmid was serially diluted to obtain a copy number of 10 8 、10 7 、10 6 、10 5 、10 4 、10 3 、10 2 The positive plasmid of copies / μl, and with the positive plasmid of these different concentrations as template, detect according to embodiment 2, the result is as follows figure 1 shown, among them, in figure 1 The positive plasmid concentrations corresponding to each amplification curve in the figure are 10 from left to right 8 、10 7 、10 6 、10 5 、10 4 、10 3 、10 2 copies / uL. Depend on figure 1It can be seen that both CLTC-TFE3 and β-actin are active, and the primers and probes of the present...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an oligonucleotide detecting CLTC-TFE3 fusion gene in a sample, a method and a kit. The oligonucleotide comprises upstream and downstream primers and probes aimed at CLTC-TFE3,and upstream and downstream primers and probes aimed at [beta]-actin reference gene. The oligonucleotide can quickly detect whether CLTC is present in a sample. TFE3 fusion gene and its expression level. The detection result completed by the invention is accurate and sensitive, and can be used for assisting to formulate an individualized treatment scheme for patients with human Xp11.2 translocation / TFE3 fusion gene related renal cell carcinoma.

Description

technical field [0001] The invention belongs to the field of biological science and biotechnology, in particular to a method for detecting CLTC-TFE3 fusion gene in a sample, an oligonucleotide and a kit, which uses fluorescent PCR technology to detect human Xp11.2 translocation / TFE3 fusion gene correlation The expression level of CLTC-TFE3 fusion gene in patients with advanced renal cell carcinoma. Background technique [0002] Xp11.2 translocation / TFE3 gene fusion-related renal cell carcinoma (referred to as Xp11.2 translocation renal cell carcinoma) is a newly recognized subtype of renal cell carcinoma, which mainly occurs in adolescents, is clinically rare, and has a high degree of malignancy. It is characterized by the balanced translocation of the Xp11.2 site in the genome, the formation of TFE3 fusion gene, and the high expression of TFE3 fusion protein. Xp11.2 translocation renal cell carcinoma is obviously different from other renal cell carcinomas in terms of molec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6851C12N15/11
CPCC12Q1/6851
Inventor 董绍斌吴鹏飞王淑一
Owner 北京艾迪康医学检验实验室有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap